Norvir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0074-3399 -
Package NDC
0074-3399-30 -
Application number
NDA209512 -
SPL ID
08f28b14-eabc-4a9a-b066-d8eda837e9e4 -
SPL set ID
2849298e-de6e-47bb-8194-56e075b33fc3 -
UNII
O3J8G9O825 -
RxCUI
152971 -
RxCUI
199249 -
RxCUI
900575 -
RxCUI
900577 -
RxCUI
1926066 -
RxCUI
1926069
What the source publishes
- Labeler
- AbbVie Inc.
- Active ingredients
- Ritonavir
- Form
- POWDER
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Norvir",
"splId": "08f28b14-eabc-4a9a-b066-d8eda837e9e4",
"labels": [
{
"setId": "2849298e-de6e-47bb-8194-56e075b33fc3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2849298e-de6e-47bb-8194-56e075b33fc3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2849298e-de6e-47bb-8194-56e075b33fc3"
}
],
"routes": [
"ORAL"
],
"labeler": "AbbVie Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 PACKET in 1 CARTON (0074-3399-30) / 1 POWDER in 1 PACKET",
"package_ndc": "0074-3399-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20170607"
}
],
"productId": "0074-3399_08f28b14-eabc-4a9a-b066-d8eda837e9e4",
"useDomain": "unknown",
"dosageForm": "POWDER",
"productNdc": "0074-3399",
"deaSchedule": null,
"genericName": "Ritonavir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RITONAVIR",
"strength": "100 mg/1"
}
],
"applicationNumber": "NDA209512",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170607",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000246",
"N0000191001",
"N0000175889",
"N0000190114",
"N0000182137",
"N0000185607",
"N0000190118",
"N0000185503",
"N0000190113",
"N0000182141",
"N0000191266",
"N0000185507",
"N0000187064",
"N0000190117"
],
"upc": [
"0300742340304"
],
"unii": [
"O3J8G9O825"
],
"rxcui": [
"152971",
"199249",
"900575",
"900577",
"1926066",
"1926069"
],
"spl_set_id": [
"2849298e-de6e-47bb-8194-56e075b33fc3"
],
"pharm_class_epc": [
"Cytochrome P450 3A Inhibitor [EPC]",
"Protease Inhibitor [EPC]"
],
"pharm_class_moa": [
"HIV Protease Inhibitors [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Cytochrome P450 2C19 Inducers [MoA]",
"Cytochrome P450 3A Inducers [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"Cytochrome P450 1A2 Inducers [MoA]",
"Cytochrome P450 2C9 Inducers [MoA]",
"Cytochrome P450 2B6 Inducers [MoA]",
"UDP Glucuronosyltransferases Inducers [MoA]"
],
"manufacturer_name": [
"AbbVie Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0074-3399_08f28b14-eabc-4a9a-b066-d8eda837e9e4"